Home » Stocks » CURE Pharmaceutical

CURE Pharmaceutical Holding Corp. (CURR)

Stock Price: $1.14 USD -0.06 (-5.00%)
Updated Oct 26, 2020 1:29 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 58.20M
Revenue (ttm) 990,000
Net Income (ttm) -10.08M
Shares Out 51.06M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $1.14
Previous Close $1.20
Change ($) -0.06
Change (%) -5.00%
Day's Open 1.20
Day's Range 1.10 - 1.20
Day's Volume 9,578
52-Week Range 1.06 - 3.5

More Stats

Market Cap 58.20M
Enterprise Value 58.10M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 51.06M
Float 29.12M
EPS (basic) -0.21
EPS (diluted) -0.26
FCF / Share -0.18
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 1.51
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 58.79
PB Ratio 2.31
Revenue 990,000
Operating Income -10.37M
Net Income -10.08M
Free Cash Flow -7.53M
Net Cash 107,000
Net Cash / Share 0.00
Gross Margin 39.60%
Operating Margin -1,047.27%
Profit Margin -1,018.20%
FCF Margin -760.81%
ROA -21.51%
ROE -54.76%
ROIC -108.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue0.620.580.180.080.18
Revenue Growth6.68%223.72%114.35%-54.12%-
Gross Profit0.390.30--0.070.07
Operating Income-13.69-7.56-7.34-3.93-1.54
Net Income-21.36-10.40-8.15-4.16-1.60
Shares Outstanding34.5425.0023.659.106.63
Earnings Per Share-0.62-0.42-0.34-0.46-0.24
Operating Cash Flow-8.10-4.10-3.56-3.52-0.40
Capital Expenditures-0.41-0.06-0.10-0.12-0.19
Free Cash Flow-8.51-4.16-3.66-3.64-0.59
Cash & Equivalents4.100.500.111.110.08
Total Debt0.796.272.400.093.97
Net Cash / Debt3.31-5.77-2.291.01-3.89
Assets32.463.402.102.841.82
Liabilities18.958.554.091.125.66
Book Value13.51-5.17-2.041.72-3.83
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name CURE Pharmaceutical Holding Corp.
Country United States
Employees 18
CEO Robert Steven Davidson

Stock Information

Ticker Symbol CURR
Stock Exchange US OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier OTCMKTS: CURR

Description

CURE Pharmaceutical Holding, an integrated drug delivery and development company, focuses on improving drug efficacy, safety, and the patient experience through its proprietary drug dosage forms and delivery systems. The company is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. It offers CURE 3068 (CUREfilm Sleep), a melatonin-containing sleep aid CUREfilm oral dissolving film (ODF) that is used as a dietary supplement under the brand name ID Life Sleep Strips; and CURE 5079, a sleep aid containing a dietary cannabinoid CUREfilm ODF under the brand name Sleep Stripzzz. The company's products in development stage include CURE 5003 (CUREfilm Blue), a sildenafil CUREfilm ODF, which is in early stage clinical development for the treatment of erectile disorder; CURE 5067 (CUREfilm D), a vitamin D3 CUREfilm ODF for oral administration that is in the optimization development stage; CURE 5200, a CUREfilm ODF substrate; CURE 5209, a CUREfilm ODF for mood enhancement as a dietary supplement; and CURE 5210 (CUREfilm Beta-Caryophyllene), a dietary cannabinoid ODF that is in early feasibility stage to target the CB2 receptor. CURE Pharmaceutical Holding Corp. has a collaboration with Canopy Growth Corporation for the development of low-dose cannabidiol oral thin films. The company was founded in 2011 and is headquartered in Oxnard, California.